Abstract

Background: Parkinson's disease is distinguished by ailments such as shaking hands,   difficulties with walking, instability, depressive disorders, anxiety, and diarrhea. PD  Patients belonging to the middle class and below exhibited the greatest prevalence of  Parkinson's disease, accounting for 40% of the cases. It is likely to be more common  among those in the middle socioeconomic class.  Aim: The objective is to gather the existing empirical data regarding the influence on   mental wellness in older adults afflicted by Parkinson's disease.  Methods and Materials: Data was collected from additional resources such as search engines and databases, specifically Scopus, PubMed Central, Google Scholar, ProQuest,  and JSTOR were consulted.  Results and   Conclusions: Furthermore, the complexity and severe negative  consequences may differ, although the impacted persons are able to adapt to both the  physical and non-physical symptoms. In order to improve the health and well-being  of senior individuals affected by Parkinson's disease, it is important for mental health   specialists, neurologists, healthcare workers, caregivers, and family members to  collaborate as a group.

• 1.   Aarsland, D., Anderson, K., Larsen, J. P., & Wentzel-Larsen, T. (2023). Mental health disorders in Parkinson's disease. In H. Bloem, A. Schrag, F. Babb, & N. Beiser (Eds.), Movement disorders (6th ed., pp. 1294-1315). Springer International Publishing.
• 2.   Ash, S., Jester, C., York, C., Kofman, O., Langey, R., Halpin, A., Firn, K., Perez, S. D., Chahine, L. M., Spindler, M., Dahodwala, N., Irwin, D. J., McMillan, C. T., Weintraub, D., & Grossman, M. (2017). Longitudinal decline in speech production in Parkinson’s disease spectrum disorders. Brain and Language, 171, 42–51. https://doi.org/10.1016/j. bandl.2017.05.001
• 3.   Baumbach, L. F., Deuschl, G., Krack, P., Volkmann, J., & Klein, J. C. (2015). Non-motor symptoms in Parkinson's disease: Management challenges and current treatment options. Journal of Neurology, Neurosurgery & Psychiatry, 86(8), 880-892
• 4.   Broeders, M., de Bie, R. M., Velseboer, D. C., Speelman, J. D., Muslimovic, D., & Schmand, B. (2013). Evolution of mild cognitive impairment in Parkinson disease. Neurology, 81(4), 346–352. https://doi.org/10.1212/ WNL.0b013e31829c5c86
• 5.   Cavanaugh, J. C., & Blanchard-Fields, F. (2015). Adult development and aging. Cengage learning.
• 7.   De La Cruz, S. P. (2017). Effectiveness of aquatic therapy for the control of pain and increased functionality in people with Parkinson’s disease: a randomized clinical trial. European Journal of Physical and Rehabilitation Medicine, 53(6). https:// doi.org/10.23736/s1973-9087.17.04647-0
• 8.   Ding, W., Lj, D., Ff, L., Han, Y., & Mu, L. (2015). Neurodegeneration and cognition in Parkinson’s disease: a review. PubMed, 19(12), 2275–2281. https://pubmed.ncbi.nlm.nih.gov/26166654
• 9.   Dauer, W. T., & Przedborski, S. (2003). Parkinson’s Disease. Neuron (Cambridge, Mass.), 39(6), 889–909. https://doi.org/10.1016/s0896-6273(03)00568-3
• 10.   Dauwerse, L., Hendrikx, A., Schipper, K., Struiksma, C., & Abma, T. (2014). Quality-of-life of patients with Parkinson’s disease. Brain Injury, 28(10), 1342–1352. https://doi.org/10.3109/026990 52.2014.916417
• 11.   Englezou, C., Nazeer, K. K., &Rajabally, Y. A. (2023). Impact of social-functioning and sleep on quality of life in chronic inflammatory demyelinating polyneuropathy. Clinical Neurology and Neurosurgery, 234, 108017. https://doi. org/10.1016/j.clineuro.2023.108017
• 12.   Fereshtehnejad, S. M., Shafieesabet, M., Farhadi, F., Hadizadeh, H., Rahmani, A., & Naderi, N. (2015). Quality of life in patients with Parkinson's disease: translation and psychometric evaluation of the Iranian version of PDQ-39. Journal of Research in Medical Sciences, 20(4), 374–381.
• 13.   Gallagher, D. A., Lees, A. J., & Schrag, A. (2010). What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?. Movement disorders: official journal of the Movement Disorder Society, 25(15), 2493–2500. https://doi.org/10.1002/mds.23394
• 14.   Gunnery, S. D., Habermann, B., Saint‐Hilaire, M., Thomas, C. A., & Tickle-Degnen, L. (2016). The Relationship between the Experience of Hypomimia and Social Wellbeing in People with Parkinson’s Disease and their Care Partners. Journal of Parkinson’s Disease, 6(3), 625–630. https://doi. org/10.3233/jpd-160782
• 15.   Jones, J. D., Kurniadi, N., Kuhn, T., Szymkowicz, S. M., Bunch, J., & Rahmani, E. (2019). Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: Analysis of the PPMI cohort. Neuropsychology (Journal), 33(8), 1111– 1120. https://doi.org/10.1037/neu0000583
• 16.   Kashif, M., Ahmad, A., Bandpei, M. a. M., Gilani, S. A., Hanif, A., & Iram, H. (2022). Combined effects of virtual reality techniques and motor imagery on balance, motor function and activities of daily living in patients with Parkinson’s disease: a randomized controlled trial. BMC Geriatrics, 22(1). https://doi. org/10.1186/s12877-022-03035-1
• 17.   Kuhlman, G. M., Flanigan, J. L., Sperling, S. A., & Barrett, M. J. (2019). Predictors of health-related quality of life in Parkinson’s disease. Parkinsonism & Related Disorders, 65, 86–90. https://doi. org/10.1016/j.parkreldis.2019.05.009
• 18.   Kulisevsky J. (2022). Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert. Tratamientofarmacológico de lossíntomasmotores de la enfermedad de Parkinson: actualización y recomendaciones de un experto. Revista de neurologia, 75(s04), S1–S10. https://doi.org/10.33588/ rn.75s04.2022217
• 19.   Lawson, R. A., Yarnall, A. J., Duncan, G. W., Breen, D. P., Khoo, T. K., Williams‐Gray, C. H., Barker, R. A., Collerton, D., Taylor, J., & Burn, D. J. (2016). Cognitive decline and quality of life in incident Parkinson’s disease: The role of attention. Parkinsonism & Related Disorders, 27, 47–53. https:// doi.org/10.1016/j.parkreldis.2016.04.009
• 20.   Malek, N. (2019). Deep brain stimulation in Parkinson’s disease. Neurology India, 67(4), 968. https://doi.org/10.4103/0028-3886.266268
• 21.   Martinez-Martin, P., Rodriguez-Blazquez, C., Kurtis, M. M., Chaudhuri, K. R., & Group, N. V. (2015). The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Movement Disorders, 30(6), 738–746.
• 22.   Mosley, P., Moodie, R., & Dissanayaka, N. (2017). Caregiver burden in Parkinson Disease: A Critical review of Recent literature. Journal of Geriatric Psychiatry and Neurology, 30(5), 235–252. https:// doi.org/10.1177/0891988717720302
• 23.   Nagano, T., Kakuma, T., Umezu, Y., & Yanagawa, T. (2021). Nutritional status and activities of daily living in patients with Parkinson’s disease. PLOS ONE, 16(2), e0246329. https://doi.org/10.1371/ journal.pone.0246329
• 24.   Nojomi, M., Mostafavian, Z., Shahidi, G. A., & Jenkinson, C. (2010). Quality of life in patients with Parkinson's disease: Translation and psychometric evaluation of the Iranian version of PDQ-39. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 15(2), 63–69.
• 25.   Northcott, S., Moss, B., Harrison, K., & Hilari, K. (2016). A systematic review of the impact of stroke on social support and social networks: associated factors and patterns of change. Clinical Rehabilitation, 30(8), 811–831. https://doi. org/10.1177/0269215515602136
• 26.   Perepezko, K., Hinkle, J. T., Shepard, M., Fischer, N., Broen, M. P. G., Leentjens, A. F., Gallo, J. J., & Pontone, G. M. (2019). Social role functioning in Parkinson’s disease: A mixed‐methods systematic review. International Journal of Geriatric Psychiatry, 34(8), 1128–1138. https://doi.org/10.1002/gps.5137
• 27.   Porcelli, S., Van Der Wee, N., Van Der Werff, S., Aghajani, M., Glennon, J., Van Heukelum, S., Mogavero, F., Lobo, A., Olivera, F. J. N., Lobo, E., Posadas, M., Dukart, J., Kozak, R., Arce, E., Ikram, M. A., Vorstman, J., Bilderbeck, A. C., Saris, I. M., Kas, M., &Serretti, A. (2019). Social brain, social dysfunction and social withdrawal. Neuroscience &Biobehavioral Reviews, 97, 10–33. https://doi. org/10.1016/j.neubiorev.2018.09.012
• 28.   Radder, D. L., Nonnekes, J., van Nimwegen, M., Eggers, C., Abbruzzese, G., Alves, G., & Bloem, B. R. (2016). Recommendations for the organization of multidisciplinary clinical care teams in Parkinson's disease. Journal of Parkinson's Disease, 6(4), 661– 667.
• 29.   Roheger, M., Kalbe, E., & Liepelt‐Scarfone, I. (2018b). Progression of cognitive decline in Parkinson’s disease. Journal of Parkinson’s Disease, 8(2), 183–193. https://doi.org/10.3233/jpd-181306
• 30.   Saeedian, R. G., Nagyová, I., Krokavcova, M., Škorvánek, M., Rosenberger, J., Gdovinová, Z., Groothoff, J. W., & Van Dijk, J. P. (2014). The role of social support in anxiety and depression among Parkinson’s disease patients. Disability and Rehabilitation, 36(24), 2044–2049. https://doi.org/1 0.3109/09638288.2014.886727
• 31.   Sapir, S., Ramig, L. O., & Fox, C. (2011). Intensive voice treatment in Parkinson’s disease: Lee Silverman Voice Treatment. Expert Review of Neurotherapeutics, 11(6), 815–830. https://doi. org/10.1586/ern.11.43
• 32.   Shao, R., He, P., Ling, B., Tan, L., Xu, L., Hou, Y., Kong, L., & Yang, Y. (2020). Prevalence of depression and anxiety and correlations between depression, anxiety, family functioning, social support and coping styles among Chinese medical students. BMC Psychology, 8(1). https://doi.org/10.1186/ s40359-020-00402-8
• 33.   Stocchi, F., Abbruzzese, G., Ceravolo, R., Cortelli, P., D'Amelio, M., De Pandis, M. F., & Pezzoli, G. (2018). Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology, 91(11), e1031–e1041.
• 34.   https://main.icmr.nic.in/. (n.d.). Indian Council of Medical Research. https://main.icmr.nic.in/
• 35.   Van Uem, J. M., Marinus, J., Canning, C. G., Van Lummel, R., Dodel, R., Liepelt-Scarfone, I., Berg, D., Morris, M. E., &Maetzler, W. (2016). Health-Related Quality of Life in patients with Parkinson’s disease—A systematic review based on the ICF model. Neuroscience &Biobehavioral Reviews, 61, 26–34. https://doi.org/10.1016/j. neubiorev.2015.11.014
• 36.   Weaver, F. M., Stroupe, K. T., Smith, B., Gonzalez, B., Huo, Z., Cao, L., ... & SoRelle, R. (2020). Impact of deep brain stimulation on health-related quality of life in early Parkinson's disease. Movement Disorders, 35(12), 2191–2198.
• 37.   Weintraub, D., Aarsland, D., Chaudhuri, K. R., Dobkin, R. D., Leentjens, A. F., Rodríguez‐Violante, M., & Schrag, A. (2022). The neuropsychiatry of Parkinson’s disease: advances and challenges. The Lancet Neurology, 21(1), 89–102. https://doi. org/10.1016/s1474-4422(21)00330-6
• 38.   World Health Organization: WHO. (2022, June 14). Launch of WHO’s Parkinson disease technical brief. World Health Organization. https://www.who.int/news/item/14-06- 2022-launch-of-who-s-parkinson-diseasetechnicalbrief#:~:text=Globally%2C%20the%20 prevalence%20of%20Parkinson,for%20any%20 other%20neurological%20disorder.
• 39.   Yazd, S. a. R., Gashtil, S., Moradpoor, M., Pishdar, S., Nabian, P., Kazemi, Z., & Naeim, M. (2023). Reducing depression and anxiety symptoms in patients with Parkinson’s disease: The effectiveness of group cognitive behavioral therapy. Parkinsonism & Related Disorders, 112, 105456. https://doi. org/10.1016/j.parkreldis.2023.105456

Data Sharing Statement

Funding